Fluvastatin sodium

• CAT Number: I005581
• CAS Number: 93957-55-2
• Molecular Formula: C24H25FNO4 • Na
• Molecular Weight: 433.5
• Purity: ≥95%
• Target: HMG-CoA Reductase
• Solubility: 10 mM in DMSO
• Storage: 3 years -20C powder
• InChIKey: ZGGHKIMDNBDHJB-CALJPSDSSA-M

Fluvastatin sodium (CAT: I005581) is a medication belonging to the class of statins, which are commonly used to lower cholesterol levels in the body. Fluvastatin works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol synthesis. By reducing the production of cholesterol, fluvastatin helps to lower total cholesterol and low-density lipoprotein (LDL) cholesterol levels in the blood. It is primarily prescribed for the treatment of hypercholesterolemia and to reduce the risk of cardiovascular events in patients with a history of coronary artery disease.

Reference

[1]. Araújo FA, Rocha MA, Capettini LS, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (fluvastatin) decreases inflammatory angiogenesis in mice. APMIS. 2012 24. [Epub ahead of print] 


[2]. Makabe S, Takahashi Y, Watanabe H, et al. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway. Atherosclerosis. 2010 Dec;213(2):377-84. 


[3]. Zhang W, Wu J, Zhou L, et al. Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway. Indian J Exp Biol. 2010 Dec;48(12):1167-74. 


[4]. Scripture CD, Pieper JA. Clinical pharmacokinetics of fluvastatin. Clin Pharmacokinet. 2001;40(4):263-81.